-
Yamaguchi on course for fourth badminton world crown
-
Swedish police name 17-year-old girl as victim in school sword attack
-
Man Utd humiliated by Hull in dismal start to Premier League season
-
South Korea sends first container ship through Arctic route
-
Anthropic market debut could break SpaceX IPO record: media
-
Trescothick eager to keep England job despite Hussey approach
-
Pope's 'couturier of the sacred' fueled by faith
-
Indonesia deploys hundreds of soldiers to tackle Borneo fires
-
Duplantis locked in on 'grinding' for big bars
-
The last lap: Fans, drivers bid fond farewell to Dutch GP
-
Stokes says decision to leave Headingley off Ashes roster 'shambolic'
-
Silesia Diamond League: four events to watch
-
New arrival Rodri to miss Elche opener: Barca's Flick
-
Russell wins Dutch GP sprint race, Antonelli fourth
-
Atletico's Alvarez to return against Villarreal: Simeone
-
Mercedes driver George Russell wins Dutch GP sprint race
-
Dozens of civilians killed, kidnapped as jihadists clash in Nigeria
-
Ukraine strikes kill two children after Russia's deadly mall attack
-
Former envoys urge joint French, UK action on Palestinian territories
-
Pope visits San Marino, before addressing Italian political gathering
-
Australia lead by 101 in 2nd Bangladesh Test as 18 wickets fall on day one
-
Trump tariffs heap up as Canada tries to curb US reliance
-
'Aura' battles leap from social media to Latin America streets
-
Australia lose three wickets after skittling Bangladesh for 64
-
US, Canada fail to reach trade pact to avert Trump tariffs
-
Bangladesh all out for 64 in 2nd Test after Starc masterclass
-
Sudan farms lie barren as El Nino leaves Nile banks dry
-
Odyssey effect: stars sell Greece to a new wave of US tourists
-
Arctic shipping a daunting prospect in hotly contested region
-
South Korea to send first container ship through Arctic route
-
In US, rare earths extracted from coal mine wastewater
-
Starc takes 5-11 to leave Bangladesh reeling in 2nd Test
-
Nakashima pounds Fritz, Bejlek beats Keys in Cincinnati upsets
-
Injured Rune withdraws from US Open
-
Canadian negotiator says 'more work to do' on US trade deal
-
Nakashima knocks out Fritz to reach Cincinnati semi-finals
-
'Solid' Clark takes solo lead at BMW Championship
-
Ukraine says 'cynical' Russian strike on shopping centre killed 16
-
Arteta hails Arsenal's desire after perfect start to title defence
-
TikTok to pay $400 mn settlement in US children's privacy case
-
Betis down Real Sociedad in La Liga opener
-
MLS fines Messi for striking an opponent
-
Mexican governor resumes job despite US drug charges
-
Gouiri double fires Marseille past Strasbourg in Ligue 1 opener
-
Arsenal rout Coventry to open Premier League season in style
-
Mavericks buy out Thompson, now reportedly bound for Heat
-
Giant-killer Bejlek overhauls Keys to reach Cincinnati semi-finals
-
England v Pakistan first Test: Three talking points
-
Man Utd agree deal for Brighton midfielder Baleba: reports
-
US, Canada push to seal trade deal as deadline nears
Medical Care Technologies (OTC PINK:MDCE) Discusses AI Vision Behind MDCE Melanoma Scan Imaging Platform
Company outlines long-term strategy surrounding AI-assisted imaging technologies and pre-screening wellness applications
MESA, AZ / ACCESS Newswire / June 4, 2026 / Medical Care Technologies Inc. (OTC PINK:MDCE), ("MDCE" or the "Company"), a technology company focused on AI-powered consumer applications and imaging technologies, today provided additional insight into the long-term strategic vision supporting the development of its MDCE Melanoma Scan Beta platform and broader AI imaging initiatives.

The Company stated that the MDCE Melanoma Scan Beta platform represents an important component of a larger technology strategy centered on AI-assisted imaging, image management systems, and future image analysis infrastructure. While the current platform remains in beta-stage development, Medical Care Technologies views the project as part of a broader effort to explore how artificial intelligence may be utilized to support future wellness-oriented imaging applications.
Medical Care Technologies believes advancements in artificial intelligence, computer vision technologies, image processing systems, and scalable software infrastructure are creating new opportunities for the development of intelligent imaging platforms capable of supporting a wide range of future use cases.
"Our vision extends beyond a single application," stated Marshall Perkins, Chief Executive Officer of Medical Care Technologies. "We are evaluating how AI-assisted imaging technologies, image analysis frameworks, and scalable software infrastructure may be applied across multiple future technology initiatives. The MDCE Melanoma Scan Beta platform serves as an important foundation within that broader strategy."
The Company noted that ongoing development activities are helping establish internal expertise and technical infrastructure related to imaging workflows, image management systems, software architecture, and future AI-assisted analytical capabilities.
Medical Care Technologies further stated that it believes imaging technologies may represent an important long-term category within preventative wellness, consumer health applications, and future digital monitoring platforms. As a result, the Company intends to continue evaluating opportunities involving AI-assisted imaging systems and related technology initiatives as part of its broader innovation strategy.
The Company emphasized that its current efforts remain focused on development, testing, refinement, and evaluation activities associated with the MDCE Melanoma Scan Beta platform. Future technology initiatives, expansion opportunities, and potential applications remain subject to ongoing research, development progress, resource availability, regulatory considerations, and market conditions.
"Our objective is to build a technology foundation that supports innovation across multiple future opportunities," added Perkins. "We believe the convergence of artificial intelligence, imaging technologies, and scalable software platforms may create meaningful opportunities for continued development and exploration."
Medical Care Technologies expects to continue providing shareholders with updates regarding platform development activities, AI imaging initiatives, testing programs, infrastructure expansion efforts, and broader technology strategy milestones as they occur.
The MDCE Melanoma Scan Beta platform remains in beta-stage development and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. The platform has not been reviewed or cleared by the U.S. Food and Drug Administration.
About Medical Care Technologies Inc.
Medical Care Technologies Inc. is a technology company focused on AI-powered consumer applications, imaging technologies, wellness platforms, authentication technologies, and digital innovation initiatives. The Company continues to evaluate opportunities involving artificial intelligence, imaging systems, software development, and emerging technology applications.
Investor / Media Contact:
Medical Care Technologies Inc.
1910 S Stapley Drive
Suite 221
Mesa, AZ 85204
+1 480-645-0750
[email protected]
X: https://x.com/medicalcaretech
Website: https://medicalcaretechnologies.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the federal securities laws. These statements involve risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include, but are not limited to, statements regarding future development initiatives, AI imaging technologies, technology strategy, testing plans, commercialization opportunities, platform expansion efforts, and future growth objectives. The Company undertakes no obligation to publicly update forward-looking statements except as required by applicable law.
SOURCE: Medical Care Technologies Inc.
View the original press release on ACCESS Newswire
N.Walker--AT